Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
02/2011
02/22/2011US7892838 Method for the in vivo modification of the synthesis activity of a metabolite by means of the modification of a gene the activity of which is not the original activity
02/22/2011US7892824 Duchenne Muscular Dystrophy (DMD), Becker Muscular Dystrophy (BMD), and X-linked Dilated Cardiomyopathy (XLDC); retains the N-terminal domain, the cysteine-rich domain, two or more repeats of the mid-rod domain, and two or more hinges of the mid-rod domain of a full-length dystrophin protein
02/22/2011US7892810 Corynephage integrase-based site-specific insertion vector system
02/22/2011US7892806 Fungal alpha-amylase variants
02/22/2011US7892804 Arabinitol dehydrogenases from Neurospora crassa
02/22/2011US7892798 Nucleic acid molecules encoding metabolic regulatory proteins from Corynebacterium glutamicum, useful for increasing the production of methionone by a microorganism
02/22/2011US7892796 Solid support assay systems and methods utilizing non-standard bases
02/22/2011US7892795 Methods and compositions for detecting BK virus
02/22/2011US7892793 Allele-specific RNA interference
02/22/2011US7892765 Methods of screening modulators of hetero-oligomeric sweet taste receptors
02/22/2011US7892744 Analysis and use of PAR1 polymorphisms for evaluating the risk of cardiovascular disorders
02/22/2011US7892743 Subtractive single label comparative hybridization
02/22/2011US7892737 Compositions, kits and methods pertaining to stability modulation of PNA oligomer/nucleic acid complexes
02/22/2011US7892733 Response element regions
02/22/2011US7892731 System and method for inhibiting the decryption of a nucleic acid probe sequence used for the detection of a specific nucleic acid
02/22/2011US7892565 Modified botulinum toxin comprising translocation, enzymatic and binding domains for use in cosmetics and treatment of pain disorders
02/22/2011CA2610929C Methods and kits for sense rna synthesis
02/22/2011CA2335730C Method for marking a ribonucleic acid and resulting marked rna fragments
02/22/2011CA2143491C A novel peptide related to human programmed cell death and dna encoding it
02/17/2011WO2011020094A1 Use of synthetic single-stranded rna (ssrna) as a therapeutic agent to activate nod2-dependent immune response against viral infection
02/17/2011WO2011019827A2 Phage displaying system expressing single chain antibody
02/17/2011WO2011017760A1 Detection and analysis of methylation in nucleic acid sequences
02/17/2011US20110041222 Artificial dna sequence with optimized leader function in 5' (5'-utr) for the improved expression of heterologous proteins in plants
02/17/2011US20110041220 Mutant gene that regulates oil-and-fat content in seed and method for regulating oil-and-fat content in seed
02/17/2011US20110041219 Promoter, promoter control elements, and combinations, and uses thereof
02/17/2011US20110041218 Method for producing sclareol
02/17/2011US20110041216 Nitrate reductases from red algae, compositions and methods of use thereof
02/17/2011US20110041215 Lipid Metabolism Protein And Uses Thereof I (BZIP Transcription Factor)
02/17/2011US20110041214 Genetic Markers For Orobanche Resistance in Sunflower
02/17/2011US20110041213 Novel bacillus thuringiensis insecticidal proteins
02/17/2011US20110041208 Promoter, promoter control elements, and combinations, and uses thereof
02/17/2011US20110041194 I-msoi homing endonuclease variants having novel substrate specificity and use thereof
02/17/2011US20110041193 Non-human mammal model of epilepsy
02/17/2011US20110041191 Animal model, and products and methods useful for the production thereof
02/17/2011US20110040082 Modifications of antimetabolite gemcitabine for incorporation in CpG oligonucleotides
02/17/2011US20110040081 METHODS, COMPOSITIONS, AND KITS FOR GENERATING rRNA-DEPLETED SAMPLES OR ISOLATING rRNA FROM SAMPLES
02/17/2011US20110040080 Infectious cDNA Clone of North American Porcine Reproductive and Respiratory Syndrome (PRRS) Virus and Uses Thereof
02/17/2011US20110040079 Infectious cDNA Clone of North American Porcine reproductive and Respiratory Syndrome (PRRS) Virus and Uses Thereof
02/17/2011US20110040077 Protein-Responsive Translational Regulatory System Using RNA-Protein Interacting Motif
02/17/2011US20110039918 Single Nucleotide Polymorphisms (SNPs) in Genes Associated with Inflammatory Diseases
02/17/2011US20110039916 Helper Virus-Free Herpesvirus Amplicon Particles and Uses Thereof
02/17/2011US20110039915 IMMUNOSTIMULATORY siRNA MOLECULES
02/17/2011US20110039914 Modified rnai polynucleotides and uses thereof
02/17/2011US20110039913 Antisense modulation of hydroxysteroid 11-beta dehydrogenase 1 expression
02/17/2011US20110039910 Modulation of apolipoprotein (a) expression
02/17/2011US20110039909 Methods and materials for reducing gli2 expression
02/17/2011US20110039780 Platelet glycoprotein ib alpha variant fusion polypeptides and methods of use thereof
02/17/2011US20110039775 Thyroid stimulating hormone fusion proteins
02/17/2011US20110039773 BMP Mutants with Decreased Susceptibility to Noggin
02/17/2011US20110039771 Small humanin-like peptides
02/17/2011US20110039734 siRNA targeting connective tissue growth factor (CTGF)
02/17/2011US20110039733 Probe, probe set, probe carrier, and testing method
02/17/2011US20110039731 Enhanced Sequencing by Hybridization Using Pools of Probes
02/17/2011US20110039728 Polynucleotides for Use as Tags and Tag Complements, Manufacture and Use Thereof
02/17/2011US20110039727 Polynucleotides for use as tags and tag complements, manufacture and use thereof
02/17/2011US20110039726 Polynucleotides for use as tags and tag complements, manufacture and use thereof
02/17/2011US20110039719 Methods and nucleic acids for the analyses of cellular proliferative disorders
02/17/2011US20110039715 Influenza b virus detection method and kit therefor
02/17/2011US20110039709 Apparatus for processing biological material
02/17/2011US20110039706 New mutated hydroxyphenylpyruvate dioxygenase, dna sequence and isolation of plants which are tolerant to hppd inhibitor herbicides
02/17/2011US20110039339 Process, Vectors and Engineered Cell Lines for Enhanced Large-Scale Transfection
02/17/2011US20110039334 Chimeric oligomeric compounds for modulation of splicing
02/17/2011US20110039325 Family 8 enzymes with xylanolytic activity
02/17/2011US20110039310 Novel gene sms 37
02/17/2011US20110039308 Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them
02/17/2011US20110039303 Microfluidic and nanofluidic devices, systems, and applications
02/17/2011US20110039275 Method for Predicting a Clinical Response of a Patient Suffering from or at Risk of Developing Cancer Towards a Given Mode of Treatment
02/17/2011US20110039273 Method for measuring dna methylation
02/17/2011US20110039266 Flowcell systems for single molecule detection
02/17/2011US20110039264 Format of Probes to Detect Nucleic Acid Differences
02/17/2011US20110039263 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt2 polypeptides and homologs thereof
02/17/2011US20110039262 Methods for detecting virulent plasmodium, for evaluating plasmodium virulence, and for screening new drugs employing the 3'utr of plasmodium sub2 and the plasmodium sub2 serine protease
02/17/2011US20110039257 Permuted and nonpermuted luciferase biosensors
02/17/2011US20110038971 Method for the Production of Human Recombinant Lysosomal Enzymes in a Cereal Endosperm
02/17/2011US20110038935 Antibodies against influenza virus and methods of use thereof
02/17/2011US20110038924 Osteoarthritis gene therapy
02/17/2011US20110038920 Wound healing compositions and treatments
02/17/2011US20110038912 Compositions and methods for delivery of glycopeptide antibiotics to medical device surfaces
02/17/2011US20110038894 Immunogenic Peptides of Tumor Associated Antigen L6 and Uses Thereof in Cancer Therapy
02/17/2011US20110038886 N-Linked Glycosylation Alteration in E0 and E2 Glycoprotein of Classical Swine Fever Virus and Novel Classical Swine Fever Virus Vaccine
02/17/2011US20110038883 He4 monoclonal antibodies and methods for their use
02/17/2011US20110038879 Immunogenic and therapeutic compositions for streptococcus pyogenes
02/17/2011US20110038877 Interleukin-6 antagonists
02/17/2011US20110038874 Anti-vegfr monoclonal antibody, method of making and uses thereof
02/17/2011US20110038871 Ccr2 inhibitors for treating conditions of the eye
02/17/2011US20110038865 Antibody- endostatin fusion protein and its variants
02/17/2011US20110038863 Methods and compositions for improving recombinant protein production
02/17/2011US20110038854 Strategy for homo- or hetero-dimerization of various proteins in solution and in cell
02/17/2011US20110038851 Treatment of synucleinopathies
02/17/2011US20110038849 Inhibitory polynucleotide compositions and methods for treating cancer
02/17/2011US20110038834 Novel avian cytokines and genetic sequences encoding same
02/16/2011EP2284277A1 Methods and apparatus for improved luminescence assays using a soluble polymer having a ligand and a plurality of electrochemiluminescent labels
02/16/2011EP2284269A2 Antisense design
02/16/2011EP2284267A2 Modulation of diacylglycerol acyltransferase 2 expression
02/16/2011EP2284266A2 Functional and hyperfunctional sirna
02/16/2011EP2283132A2 Selective 5' ligation tagging of rna
02/16/2011EP2282744A1 Oligomeric compounds comprising tricyclic nucleosides and methods for their use
02/16/2011EP1766010B1 Antisense oligonucleotides for inducing exon skipping and methods of use thereof
02/16/2011CN101978069A Markers and methods for assessing and treating severe or persistant asthma and tnf related disorders
02/16/2011CN101977933A Biomarkers